Moore Capital Management’s CME Group CME Stock Holding History

Moore Capital Management’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.3M	Hold	45,000	–	–	0.27%	61
2025 Q4	$12.3M	Hold	45,000	–	–	0.18%	133
2025 Q3	$12.2M	Hold	45,000	–	–	0.17%	128
2025 Q2	$12.4M	Hold	45,000	–	–	0.16%	117
2025 Q1	$11.9M	Sell	45,000 -1,606	-3%	-$396K	0.25%	86
2024 Q4	$10.8M	Buy	46,606 +1,606	+4%	+$369K	0.12%	166
2024 Q3	$9.93M	Hold	45,000	–	–	0.18%	146
2024 Q2	$8.85M	Hold	45,000	–	–	0.15%	147
2024 Q1	$9.69M	Hold	45,000	–	–	0.15%	130
2023 Q4	$9.48M	Hold	45,000	–	–	0.16%	100
2023 Q3	$9.01M	Hold	45,000	–	–	0.17%	100
2023 Q2	$8.34M	Hold	45,000	–	–	0.14%	116
2023 Q1	$8.62M	Hold	45,000	–	–	0.18%	105
2022 Q4	$7.57M	Hold	45,000	–	–	0.18%	109
2022 Q3	$7.97M	Hold	45,000	–	–	0.19%	102
2022 Q2	$9.21M	Hold	45,000	–	–	0.24%	90
2022 Q1	$10.7M	Hold	45,000	–	–	0.27%	68
2021 Q4	$10.3M	Hold	45,000	–	–	0.2%	99
2021 Q3	$8.7M	Hold	45,000	–	–	0.13%	155
2021 Q2	$9.57M	Hold	45,000	–	–	0.14%	146
2021 Q1	$9.19M	Hold	45,000	–	–	0.12%	151
2020 Q4	$8.19M	Hold	45,000	–	–	0.09%	161
2020 Q3	$7.53M	Hold	45,000	–	–	0.14%	137
2020 Q2	$7.31M	Hold	45,000	–	–	0.2%	113
2020 Q1	$7.78M	Hold	45,000	–	–	0.32%	71
2019 Q4	$9.03M	Sell	45,000 -60,032	-57%	-$12.3M	0.3%	92
2019 Q3	$22.2M	Hold	105,032	–	–	0.89%	22
2019 Q2	$20.4M	Hold	105,032	–	–	0.48%	48
2019 Q1	$17.3M	Hold	105,032	–	–	0.53%	56
2018 Q4	$19.8M	Hold	105,032	–	–	0.78%	21
2018 Q3	$17.9M	Sell	105,032 -96,280	-48%	-$16.2M	0.38%	46
2018 Q2	$33M	Buy	201,312 +96,280	+92%	+$15.7M	0.81%	29
2018 Q1	$17M	Hold	105,032	–	–	0.34%	73
2017 Q4	$15.3M	Hold	105,032	–	–	0.28%	86
2017 Q3	$14.3M	Hold	105,032	–	–	0.28%	92
2017 Q2	$13.2M	Hold	105,032	–	–	0.4%	77
2017 Q1	$12.5M	Sell	105,032 -53	-0.1%	-$6.37K	0.34%	74
2016 Q4	$12.1M	Buy	105,085 +53	+0.1%	+$5.9K	0.39%	59
2016 Q3	$11M	Hold	105,032	–	–	0.38%	65
2016 Q2	$10.2M	Hold	105,032	–	–	0.4%	73
2016 Q1	$10.1M	Hold	105,032	–	–	0.41%	75
2015 Q4	$9.52M	Hold	105,032	–	–	0.3%	92
2015 Q3	$9.74M	Hold	105,032	–	–	0.46%	54
2015 Q2	$9.77M	Hold	105,032	–	–	0.21%	107
2015 Q1	$9.95M	Hold	105,032	–	–	0.22%	95
2014 Q4	$9.31M	Buy	105,032 +32	+0%	+$2.71K	0.29%	94
2014 Q3	$8.39M	Hold	105,000	–	–	0.2%	145
2014 Q2	$7.45M	Hold	105,000	–	–	0.18%	131
2014 Q1	$7.77M	Hold	105,000	–	–	0.16%	136
2013 Q4	$8.24M	Hold	105,000	–	–	0.13%	147
2013 Q3	$7.76M	Hold	105,000	–	–	0.16%	112
2013 Q2	$7.97M	Buy	+105,000	New	+$6.89M	0.19%	104

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Moore Capital Management's CME Position: Q1 2026 in Review

Moore Capital Management held its CME Group (CME) position steady in Q1 2026 at 45,000 shares worth $13.3M. The position accounts for 0.27% of the portfolio, ranked #61.

Moore Capital Management first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $33M in Q2 2018. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Moore Capital Management held 45,000 shares of CME Group worth $13.3M as of Q1 2026.
Moore Capital Management left its CME Group share count unchanged in Q1 2026.
CME Group made up 0.27% of Moore Capital Management's portfolio in Q1 2026, its #61 holding.
Moore Capital Management first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
Moore Capital Management's CME Group position peaked at $33M in Q2 2018.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Moore Capital Management's 13F filing for Q1 2026, filed 15 May 2026.